Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
2007/12/18 by Richard E. Randall, Stephen Goodbourn · 34 citations
Immunology and Microbiology · Biochemistry, Genetics and Molecular Biology · Medicine · #interferon and immune responses #Virus-based gene therapy research #Herpesvirus Infections and Treatments
paper · doi:10.1099/vir.0.83391-0
Abstract
The interferon (IFN) system is an extremely powerful antiviral response that is capable of controlling most, if not all, virus infections in the absence of adaptive immunity. However, viruses can still replicate and cause disease in vivo, because they have some strategy for at least partially circumventing the IFN response. We reviewed this topic in 2000 [Goodbourn, S., Didcock, L. & Randall, R. E. (2000). J Gen Virol 81, 2341-2364] but, since then, a great deal has been discovered about the molecular mechanisms of the IFN response and how different viruses circumvent it. This information is of fundamental interest, but may also have practical application in the design and manufacture of attenuated virus vaccines and the development of novel antiviral drugs. In the first part of this review, we describe how viruses activate the IFN system, how IFNs induce transcription of their target genes and the mechanism of action of IFN-induced proteins with antiviral action. In the second part, we describe how viruses circumvent the IFN response. Here, we reflect upon possible consequences for both the virus and host of the different strategies that viruses have evolved and discuss whether certain viruses have exploited the IFN response to modulate their life cycle (e.g. to establish and maintain persistent/latent infections), whether perturbation of the IFN response by persistent infections can lead to chronic disease, and the importance of the IFN system as a species barrier to virus infections. Lastly, we briefly describe applied aspects that arise from an increase in our knowledge in this area, including vaccine design and manufacture, the development of novel antiviral drugs and the use of IFN-sensitive oncolytic viruses in the treatment of cancer.
Cited by
- Adenoviruses: update on structure and function
- Innate cellular responses to rotavirus infection
- Death mechanisms in epithelial cells following rotavirus infection, exposure to inactivated rotavirus or genome transfection
- Association of innate immune activation with latent Epstein-Barr virus in active MS lesions
- A common form of dominant human IFNAR1 deficiency impairs IFN-α and -ω but not IFN-β-dependent immunity
- IFNβ‐dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
- Viral Evolution Under Physical Constraints: Decay, Mutation, and Transmission as a Constrained Optimization Problem
- Modulation of host cell responses and evasion strategies for porcine reproductive and respiratory syndrome virus
- Amino acids at positions 273 and 394 in rabies virus nucleoprotein are important for both evasion of host RIG-I-mediated antiviral response and pathogenicity
- Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded. [europepmc]
- Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex. [europepmc]
- Type I interferons: crucial participants in disease amplification in autoimmunity. [europepmc]
- Viral tricks to grid-lock the type I interferon system. [europepmc]
- The PRRSV replicase: exploring the multifunctionality of an intriguing set of nonstructural proteins. [europepmc]
- Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. [europepmc]
- Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral. [europepmc]
- Mosquito RNAi is the major innate immune pathway controlling arbovirus infection and transmission. [europepmc]
- IRF7: activation, regulation, modification and function. [europepmc]
- A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon. [europepmc]
- Interferon-stimulated genes and their antiviral effector functions. [europepmc]
- Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation. [europepmc]
- Evasion of influenza A viruses from innate and adaptive immune responses. [europepmc]
- MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment. [europepmc]
- Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy. [europepmc]
- Interferon induction and function at the mucosal surface. [europepmc]
- Relative resistance of HIV-1 founder viruses to control by interferon-alpha. [europepmc]
- TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity. [europepmc]
- Membranous replication factories induced by plus-strand RNA viruses. [europepmc]
- Human IFNAR2 deficiency: Lessons for antiviral immunity. [europepmc]
- Regulatory evolution of innate immunity through co-option of endogenous retroviruses. [europepmc]
- Human Coronaviruses: A Review of Virus-Host Interactions. [europepmc]
- A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses. [europepmc]
- Comparative Structure and Function Analysis of the RIG-I-Like Receptors: RIG-I and MDA5. [europepmc]
- Single-cell transcriptomics identifies an effectorness gradient shaping the response of CD4 + T cells to cytokines. [europepmc]
Related